TFRC and leukemia: Co-culture of the A2-CAR+TCRdeficient Tregs (A2-CAR Treg) with NALM6, an HLA-A2-positive B cell-derived leukemia cell line, led to a marked and specific upregulation of surface CD71 expression, demonstrating the antigen-driven activation of the edited cells.